VNDA

VNDA Earnings Preview

Vanda Pharmaceuticals Inc. · Healthcare · $413M

14d until earnings

VNDA Earnings

Wednesday, May 06 2026
Revenue Estimate
$55M
Current Price
$6.99

Our Position

bullish

FDA approves Bysanti tablets, stock surges 34%

structured data est. revisions rising (+63.0pp / 30d)

This is a binary catalyst event — hard regulatory approval that de-risks a key product and opens a new revenue stream. The market's immediate 34% pop reflects the approval's significance, but the real test is execution: whether Bysanti gains market adoption and drives sustained revenue growth for a biotech that's historically been execution-dependent.

Watch: Watch Q2 and Q3 prescriptions and revenue guidance for Bysanti. That will tell you whether this approval translates to a durable business driver or becomes a one-time pop that fades as market expectations reset.

Data Signal Summary

2 bullish
1 bearish
Insider buying cluster Put/call 0.0 (bullish skew) Price downtrend

Key Context

Insider Activity
selling
Price Trend
downtrend
From 52w High
-6.2%
Est. Revisions (30d)
-0.3% 0up/3dn
Analyst Target (mean)
$16 $8–$24 +122%
Options P/C Ratio
0.02
Est. Dispersion
65% 5 analysts
Insider Cluster
strong buy (officer)
Fund Convergence
strong Renaissance, Two Sigma, D.E. Shaw, Citadel

Recent Activity

insider trades 35 transactions
Sell · POLYMEROPOULOS MIHAEL HRISTOS (Chief Executive Officer) ·156,235 shares ·$1,276,971
Sell · BIRZNIEKS GUNTHER (Officer) ·42,431 shares ·$350,730
Sell · WILLIAMS TIMOTHY IAN (General Counsel) ·42,434 shares ·$350,755
Sell · WIJKSTROM JOAKIM PER (Officer) ·30,800 shares ·$254,590
Sell · MORAN KEVIN PATRICK (Chief Financial Officer) ·42,442 shares ·$350,821
30 more
Sell · HONORE TAGE ·30,000 shr ·$240,900
Award · POLYMEROPOULOS MIHAEL HRISTOS ·525,000 shr
Award · BIRZNIEKS GUNTHER ·125,000 shr
Award · WILLIAMS TIMOTHY IAN ·125,000 shr
Award · WIJKSTROM JOAKIM PER ·125,000 shr
Award · MORAN KEVIN PATRICK ·125,000 shr
Buy · POLYMEROPOULOS MIHAEL HRISTOS ·10,000 shr ·$41,500
Sell · MITCHELL STEPHEN RAY ·7,000 shr ·$32,130
Award · DUGAN RICHARD W ·59,225 shr
Award · CHROUSOS PHAEDRA ·59,225 shr
Award · WARD ANNE SEMPOWSKI ·59,225 shr
Award · MITCHELL STEPHEN RAY ·59,225 shr
Award · HONORE TAGE ·59,225 shr
Buy · POLYMEROPOULOS MIHAEL HRISTOS ·10,000 shr ·$43,995
Buy · POLYMEROPOULOS MIHAEL HRISTOS ·20,000 shr ·$84,472
Buy · POLYMEROPOULOS MIHAEL HRISTOS ·10,000 shr ·$50,150
Buy · POLYMEROPOULOS MIHAEL HRISTOS ·10,000 shr ·$50,200
Buy · POLYMEROPOULOS MIHAEL HRISTOS ·10,000 shr ·$47,050
Buy · POLYMEROPOULOS MIHAEL HRISTOS ·10,000 shr ·$47,600
Buy · POLYMEROPOULOS MIHAEL HRISTOS ·10,000 shr ·$47,650
Buy · POLYMEROPOULOS MIHAEL HRISTOS ·10,000 shr ·$44,640
Buy · MORAN KEVIN PATRICK ·2,000 shr ·$8,779
Award · POLYMEROPOULOS MIHAEL HRISTOS ·450,000 shr
Sell · MITCHELL STEPHEN RAY ·5,000 shr ·$25,863
Sell · MORAN KEVIN PATRICK ·2,251 shr ·$13,327
Award · CHROUSOS PHAEDRA ·21,887 shr
Award · DUGAN RICHARD W ·20,529 shr
Award · WARD ANNE SEMPOWSKI ·20,529 shr
Award · MITCHELL STEPHEN RAY ·20,529 shr
Award · HONORE TAGE ·20,529 shr